The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence

Journal of Cellular Physiology

Volumn 227, Issue 2, 2012, Pages 508-513

  Helmbold, Heike ^a   Galderisi, Umberto ^b   Bohn, Wolfgang ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; PROTEIN P107; PROTEIN P130; PROTEIN P21; PROTEIN P53; RAS PROTEIN; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL TRANSFORMATION; DNA DAMAGE; ENZYME ACTIVATION; GENE INACTIVATION; GENE LOSS; HUMAN; IN VIVO STUDY; MITOSIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

CELL AGING; CELL CYCLE; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RETINOBLASTOMA-LIKE PROTEIN P130;

EID: 82155188547     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22786     Document Type: Review

References (109)

1. Alexander K, Hinds PW. 2001. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Mol Cell Biol 21: 3616-3631.
2. Amato A, Lentini L, Schillaci T, Iovino F, Di Leonardo A. 2009. RNAi mediated acute depletion of retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation. BMC Cell Biol 10: 79.
3. Aparicio OM, Stout AM, Bell. SP. 1999. Differential assembly of Cdc45p and DNA polymerases at early and late origins of DNA replication. Proc Natl Acad Sci U S A 96: 9130-9135.
4. Araki K, Nakajima Y, Eto K, Ikeda MA. 2003. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene 22: 7632-7641.
5. Bagheri-Yarmand R, Nanos-Webb A, Biernacka A, Bui T, Keyomarsi K. 2010. Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C. Cancer Res 70: 5085-5095.
6. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506.
7. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
8. Bindra RS, Glazer PM. 2007. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene 26: 2048-2057.
9. Bindra RS, Schaffer PJ, Meng A, Woo J, Maseide K, Roth ME, Lizardi P, Hedley DW, Bristow RG, Glazer PM. 2004. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol 24: 8504-8518.
10. Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, Pierce AJ, Bristow RG, Classon MK, Glazer PM. 2005. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 65: 11597-12604.
11. Bosco G, Du W, Orr-Weaver TL. 2001. DNA replication control through interaction of E2F-RB and the origin recognition complex. Nat Cell Biol 3: 289-295.
12. Bosco EE, Mayhew CN, Hennigan RF, Sage J, Jacks T, Knudsen ES. 2004. RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res 32: 25-34.
13. Brown JP, Wei W, Sedivy JM. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831-834.
14. Buchkovich K, Duffy LA, Harlow E. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58: 1097-1105.
15. Caldon CE, Musgrove EA. 2010. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 5: 2.
16. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, Eckhaus M, Ried T, Bonner WM, Nussenzweig A. 2003. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114: 371-383.
17. Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC, Roninson IB. 2000. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19: 2165-2170.
18. Chen PL, Scully P, Shew JY, Wang JY, Lee. WH. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198.
19. Chen J, Yu Z, Ford BN, Brackley ME, Haesevoets RJ, Khaidakov M, Glickman BW. 2000. Screening a human population sample for DNA repair gene deficiencies utilizing the protein truncation test. Environ Mol Mutagen 36: 228-234.
20. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. 2005. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
21. Cheng L, Rossi F, Fang W, Mori T, Cobrinik D. 2000. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells. J Biol Chem 275: 30317-30325.
22. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, Dickins RA, Narita M, Zhang M, Lowe. SW. 2010. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17: 376-387.
23. Chow LM, Endersby R, Zhu X, Rankin S, Qu C, Zhang J, Broniscer A, Ellison DW, Baker SJ. 2011. Cooperativity within among Pten p53 Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell 19: 305-316.
24. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
25. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A. 1994. p130/Rb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556-5560.
26. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10: 1633-1644.
27. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M. 2005. Tumour biology: Senescence in premalignant tumours. Nature 436: 642.
28. Cook JG, Park CH, Burke TW, Leone G, DeGregori J, Engel A, Nevins JR. 2002. Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci U S A 99: 1347-1352.
29. Costanzo V, Shechter D, Lupardus PJ, Cimprich KA, Gottesman M, Gautier J. 2003. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 11: 203-213.
30. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Khalili BAK, Giordano A. 1997. A unique domain of Rb2/p130 acts as an inhibitor of Cdk2 kinase activity. J Biol Chem 272: 20971-20974.
31. DeCaprio JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston DM. 1992. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci U S A 89: 1795-1798.
32. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
33. Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC Jr, Squire JA, Gallie BL. 2008. Loss of RB1 induces non-proliferative retinoma: Increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 17: 1363-1372.
34. Drosten M, Dhawahir A, Sum EY, Urosevic J, Lechuga CG, Esteban LM, Castellano E, Guerra C, Santos E, Barbacid M. 2010. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. Embo J 29: 1091-1104.
35. Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH. 1993. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A 90: 11034-11038.
36. Edwards MC, Tutter AV, Cvetic C, Gilbert CH, Prokhorova TA, Walter JC. 2002. MCM 2-7 complexes bind chromatin in a distributed pattern surrounding the origin recognition complex in Xenopus egg extracts. J Biol Chem 277: 33049-33057.
37. Eguchi T, Takaki T, Itadani H, Kotani H. 2007. RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene. Oncogene 26: 509-520.
38. Ekholm SV, Reed. SI. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12: 676-684.
39. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed. SI. 2004. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 165: 789-800.
40. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. 1998. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci U S A 95: 10493-10498.
41. Furstenthal L, Kaiser BK, Swanson C, Jackson PK. 2001. Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication. J Cell Biol 152: 1267-1278.
42. Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA, Pilch DR, Rogakou EP, Celeste A, Chen HT, Nussenzweig A, Aladjem MI, Bonner WM, Pommier Y. 2003. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem 278: 20303-20312.
43. Galderisi U, Helmbold H, Squillaro T, Alessio N, Komm N, Khadang B, Cipollaro M, Bohn W, Giordano A. 2009. In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes. Stem Cells Dev 18: 1033-1042.
44. Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, Roberts JM, Kaldis P, Clurman BE, Sicinski P. 2007. Kinase-independent function of cyclin E. Mol Cell 25: 127-139.
45. Gire V, Wynford-Thomas D. 1998. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol 18: 1611-1621.
46. Gladden AB, Diehl JA. 2003. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding. J Biol Chem 278: 9754-9760.
47. Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D, Bartek J, Jackson SP. 2003. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421: 952-956.
48. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P, Wyche JH. 2002. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 277: 17154-17160.
49. Haupt Y, Rowan S, Oren. M. 1995. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10: 1563-1571.
50. Hayflick L, Moorhead PS. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
51. Helmbold H, Komm N, Deppert W, Bohn. W. 2009. Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene 28: 3456-3467.
52. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C. 2004. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430: 797-802.
53. Howard CM, Claudio PP, De Luca A, Stiegler P, Jori FP, Safdar NM, Caputi M, Khalili K, Giordano A. 2000. Inducible Rb2/p130 expression and growth-suppressive mechanisms: Evidence of a Rb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. Cancer Res 60: 2737-2744.
54. Hydbring P, Bahram F, Su Y, Tronnersjo S, Hogstrand K, von der Lehr N, Sharifi HR, Lilischkis R, Hein N, Wu S, Vervoorts J, Henriksson M, Grandien A, Luscher B, Larsson LG. 2010. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci U S A 107: 58-63.
55. Iavarone A, Massague J. 1999. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19: 916-922.
56. Jackson JG, Pereira-Smith OM. 2006. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 26: 2501-2510.
57. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. 2010. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest 120: 3296-3309.
58. Kapic A, Helmbold H, Reimer R, Klotzsche O, Deppert W, Bohn. W. 2006. Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ 13: 324-334.
59. Keck JM, Summers MK, Tedesco D, Ekholm-Reed S, Chuang LC, Jackson PK, Reed. SI. 2007. Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1). J Cell Biol 178: 371-385.
60. Lazzerini Denchi E, Attwooll C, Pasini D, Helin K. 2005. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 25: 2660-2672.
61. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA. 1998. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol Cell Biol 18: 7455-7465.
62. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
63. Lou Z, Chini CC, Minter-Dykhouse K, Chen. J. 2003. Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control. J Biol Chem 278: 13599-13602.
64. Macaluso M, Cinti C, Russo G, Russo A, Giordano A. 2003. Rb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and Rb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene 22: 3511-3517.
65. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T. 2003. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23: 1044-1053.
66. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605.
67. Mallette FA, Ferbeyre G. 2007. The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 6: 1831-1836.
68. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. 2007. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 21: 43-48.
69. Malumbres M, Barbacid M. 2003. RAS oncogenes: The first 30 years. Nat Rev Cancer 3: 459-465.
70. Matsumoto Y, Maller JL. 2004. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 306: 885-888.
71. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166.
72. Medema RH, Herrera RE, Lam F, Weinberg RA. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A 92: 6289-6293.
73. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
74. Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A, Fung. YK. 1989. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246: 1300-1303.
75. Mimura S, Masuda T, Matsui T, Takisawa H. 2000. Central role for cdc45 in establishing an initiation complex of DNA replication in Xenopus egg extracts. Genes Cells 5: 439-452.
76. Mittnacht S, Paterson H, Olson MF, Marshall CJ. 1997. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr Biol 7: 219-221.
77. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 13: 1181-1189.
78. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe. SW. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
79. Nasmyth K. 2005. How might cohesin hold sister chromatids together? Philos Trans R Soc Lond B Biol Sci 360: 483-496.
80. Nguyen H, Gitig DM, Koff. A. 1999. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol Cell Biol 19: 1190-1201.
81. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10: 886-895.
82. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA, Ewen. ME. 1997a. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177-181.
83. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA, Ewen. ME. 1997b. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177-181.
84. Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, DiMaio. D. 2004. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res 64: 3079-3086.
85. Reimann M, Lee S, Loddenkemper C, Dorr JR, Tabor V, Aichele P, Stein H, Dorken B, Jenuwein T, Schmitt CA. 2010. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell 17: 262-272.
86. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. 2002. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256.
87. Rizzolio F, Esposito L, Muresu D, Fratamico R, Jaraha R, Caprioli GV, Giordano A. 2010. RB gene family: Genome-wide ChIP approaches could open undiscovered roads. J Cell Biochem 109: 839-843.
88. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. 2007. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9: 493-505.
89. Seluanov A, Mittelman D, Pereira-Smith OM, Wilson JH, Gorbunova V. 2004. DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc Natl Acad Sci U S A 101: 7624-7629.
90. Shamma A, Takegami Y, Miki T, Kitajima S, Noda M, Obara T, Okamoto T, Takahashi C. 2009. Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15: 255-269.
91. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
92. Sogo JM, Lopes M, Foiani M. 2002. Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 297: 599-602.
93. Spruck CH, Won KA, Reed. SI. 1999. Deregulated cyclin E induces chromosome instability. Nature 401: 297-300.
94. Srinivasan SV, Mayhew CN, Schwemberger S, Zagorski W, Knudsen ES. 2007. RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors. J Biol Chem 282: 23867-23877.
95. Stein GH, Drullinger LF, Soulard A, Dulic V. 1999. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19: 2109-2117.
96. Sterner JM, Dew-Knight S, Musahl C, Kornbluth S, Horowitz JM. 1998. Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol 18: 2748-2757.
97. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ. 2003. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421: 961-966.
98. Takahashi Y, Rayman JB, Dynlacht BD. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.
99. Tedesco D, Lukas J, Reed. SI. 2002. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 16: 2946-2957.
100. Tetzlaff MT, Yu W, Li M, Zhang P, Finegold M, Mahon K, Harper JW, Schwartz RJ, Elledge SJ. 2004. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A 101: 3338-3345.
101. van Harn T, Foijer F, van Vugt M, Banerjee R, Yang F, Oostra A, Joenje H, te Riele H. 2010. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev 24: 1377-1388.
102. Vlach J, Hennecke S, Amati B. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Embo J 16: 5334-5344.
103. Weinberg WC, Azzoli CG, Chapman K, Levine AJ, Yuspa SH. 1995. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene 10: 2271-2279.
104. Welcker M, Clurman BE. 2008. FBW7 ubiquitin ligase: A tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8: 83-93.
105. Xouri G, Dimaki M, Bastiaens PI, Lygerou Z. 2007. Cdt1 interactions in the licensing process: A model for dynamic spatiotemporal control of licensing. Cell Cycle 6: 1549-1552.
106. You Z, Bailis JM, Johnson SA, Dilworth SM, Hunter T. 2007. Rapid activation of ATM on DNA flanking double-strand breaks. Nat Cell Biol 9: 1311-1318.
107. Zhang S, Ramsay ES, Mock. BA. 1998. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc Natl Acad Sci U S A 95: 2429-2434.
108. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean. DC. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101: 79-89.
109. Zheng L, Flesken-Nikitin A, Chen PL, Lee. WH. 2002. Deficiency of retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res 62: 2498-2502.